Table 4.

Concomitant medications^*†

Drug class	Oclacitinib group [n = 216; n (%)]‡	Placebo group [n = 220; n (%)]‡
Endectocides	145 (67.1)	150 (68.2)
Ectoparaciticides, insecticides and repellents	105 (48.6)	101 (45.9)
Canine vaccines	26 (12.0)	25 (11.4)
Glucosamine (with and without chondroitin) and nonsteroidal anti-inflammatory products	6 (2.8)	17 (7.7)
Systemic antibacterials§	17 (7.9)	11 (5.0)
Omega-3 fatty acid preparations	7 (3.2)	7 (3.2)
Otologicals	13 (6.0)	6 (2.7)
Ophthalmologicals	2 (0.9)	5 (2.3)

^*Administered to ≥2% of the oclacitinib-treated dogs.

^†Administered in decreasing order of frequency in the oclacitinib treatment group.

^‡Number and percentage are given on a per animal basis.

^§Administered during the continuation phase.